methamphetamine has been researched along with nifedipine in 12 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 4 (33.33) | 18.2507 |
| 2000's | 2 (16.67) | 29.6817 |
| 2010's | 6 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Ambroso, JL; Ayrton, AD; Baines, IA; Bloomer, JC; Chen, L; Clarke, SE; Ellens, HM; Harrell, AW; Lovatt, CA; Reese, MJ; Sakatis, MZ; Taylor, MA; Yang, EY | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Masukawa, Y; Misawa, M; Shiozaki, Y; Suzuki, T | 1 |
| Calder, L; Clikeman, J; Finnegan, KT; Karler, R; Wei, S | 1 |
| Belorkar, NR; Khanzode, SD; Kharkar, VT; Mahakalkar, SM; Manekar, MS | 1 |
| Hori, Y; Matsumiya, T; Takeda, H; Tsuji, M | 1 |
| Blake, BL; Breese, GR; Devine, DP; Egami, K; Jinnah, HA; Muehlmann, AM | 1 |
| Kurokawa, K; Ohkuma, S; Shibasaki, M | 1 |
| Kurokawa, K; Mizuno, K; Ohkuma, S; Shibasaki, M | 1 |
| Bae, EK; Harvey, BK; Hsu, MJ; Richie, CT; Wang, Y; Wu, KJ; Yu, SJ | 1 |
1 review(s) available for methamphetamine and nifedipine
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
11 other study(ies) available for methamphetamine and nifedipine
| Article | Year |
|---|---|
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Preclinical strategy to reduce clinical hepatotoxicity using in vitro bioactivation data for >200 compounds.
Topics: Chemical and Drug Induced Liver Injury; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Decision Trees; Drug Evaluation, Preclinical; Drug-Related Side Effects and Adverse Reactions; Glutathione; Humans; Liver; Pharmaceutical Preparations; Protein Binding | 2012 |
Effects of calcium antagonists on the cocaine- and methamphetamine-induced conditioned place preference.
Topics: Animals; Calcium Channel Blockers; Cocaine; Conditioning, Psychological; Diltiazem; Dose-Response Relationship, Drug; Flunarizine; Male; Methamphetamine; Nifedipine; Rats; Rats, Inbred Strains | 1992 |
Effects of L-type calcium channel antagonists on the serotonin-depleting actions of MDMA in rats.
Topics: 3,4-Methylenedioxyamphetamine; Animals; Brain Chemistry; Calcium Channel Blockers; Cerebral Cortex; Flunarizine; Haloperidol; Hippocampus; Male; Methamphetamine; N-Methyl-3,4-methylenedioxyamphetamine; Nifedipine; Rats; Rats, Sprague-Dawley; Seizures; Serotonin; Stereotyped Behavior; Verapamil | 1993 |
Effect of pre-treatment of some calcium channel blockers on catalepsy and stereotypic behaviour in rats.
Topics: Animals; Calcium Channel Blockers; Catalepsy; Central Nervous System Depressants; Central Nervous System Stimulants; Diltiazem; Female; Haloperidol; Male; Methamphetamine; Nifedipine; Rats; Rats, Wistar; Stereotyped Behavior; Verapamil | 1996 |
Differentiation of the inhibitory effects of calcium antagonists on abnormal behaviors induced by methamphetamine or phencyclidine.
Topics: Amygdala; Animals; Behavior, Animal; Calcium Channel Blockers; Caudate Nucleus; Central Nervous System Stimulants; Dopamine Uptake Inhibitors; Flunarizine; Injections, Intraperitoneal; Male; Methamphetamine; Microinjections; Motor Activity; Nicardipine; Nifedipine; Phencyclidine; Putamen; Rats; Rats, Wistar | 1998 |
Nifedipine suppresses self-injurious behaviors in animals.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Animals; Behavior, Animal; Calcium Channel Agonists; Calcium Channel Blockers; Central Nervous System Stimulants; Disease Models, Animal; Female; Male; Methamphetamine; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Nifedipine; Oxidopamine; Pemoline; Pregnancy; Rats; Rats, Long-Evans; Rats, Sprague-Dawley; Self-Injurious Behavior; Sympatholytics | 2007 |
Upregulation of L-type Ca(v)1 channels in the development of psychological dependence.
Topics: Animals; Brain; Brain Chemistry; Calcium Channel Blockers; Calcium Channels, L-Type; Calcium Signaling; Cocaine; Disease Models, Animal; Frontal Lobe; Limbic System; Male; Methamphetamine; Mice; Morphine; Nifedipine; Substance-Related Disorders; Up-Regulation | 2010 |
Regulation of ryanodine receptors by dopamine D1 receptors during methamphetamine-induced place conditioning.
Topics: Animals; Benzazepines; Brain; Calcium Channel Blockers; Calcium Channels, L-Type; Central Nervous System Stimulants; Conditioning, Psychological; Dantrolene; Dopamine Antagonists; Dose-Response Relationship, Drug; Gene Expression Regulation; Injections, Intraventricular; Male; Methamphetamine; Mice; Muscle Relaxants, Central; Nifedipine; Receptors, Dopamine D1; Ryanodine Receptor Calcium Release Channel; Sulpiride | 2010 |
Methamphetamine induces a rapid increase of intracellular Ca(++) levels in neurons overexpressing GCaMP5.
Topics: Analysis of Variance; Animals; Calcium; Calcium Channel Blockers; Calcium Channels; Calcium-Binding Proteins; Calmodulin; Cells, Cultured; Cerebral Cortex; Dantrolene; Dizocilpine Maleate; Dopamine Agents; Excitatory Amino Acid Antagonists; Female; Glutamic Acid; Green Fluorescent Proteins; Indicators and Reagents; Male; Methamphetamine; Muscle Relaxants, Central; Neurons; Nifedipine; Rats, Sprague-Dawley; Recombinant Fusion Proteins; Signal Transduction | 2016 |